Pain Measured by NRS and EEG in Acute Pulpitis
Launched by CLEVELAND DENTAL INSTITUTE · Jul 24, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how people with acute pulpitis, a painful dental condition, experience pain, especially those who do not respond well to a common pain relief method called the inferior alveolar nerve block (IANB). Researchers want to learn more about the pain these patients feel by using two methods: one where patients rate their pain on a scale from 0 to 10, and another that looks at brain activity using a technique called electroencephalography (EEG). By combining these approaches, the study hopes to find a better understanding of pain and ultimately improve pain management strategies for patients who struggle with this condition.
To be eligible for the study, participants should be adults aged 18 to 50 who have been diagnosed with symptomatic acute pulpitis and are resistant to the IANB method of pain relief. Participants must be able to understand and agree to the study procedures. People with certain medical conditions, those who are pregnant or breastfeeding, and anyone taking medications that affect pain perception will not be able to participate. If you join the study, you can expect to share your pain levels and undergo a safe brain activity test, helping researchers learn more about managing dental pain in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged \[18-50 years\]. Clinically diagnosed with symptomatic acute pulpitis based on dental examination and radiographic findings.
- • Demonstrates resistance to inferior alveolar nerve block (IANB). Willing and able to provide informed consent to participate in the study. Able to communicate effectively in the language used for study procedures.
- Exclusion Criteria:
- • Individuals with known neurological or psychiatric disorders affecting pain perception.
- • Pregnant individuals or those breastfeeding at the time of the study. History of severe allergies or adverse reactions to local anesthetics or EEG gel.
- • Presence of significant medical conditions that may contraindicate dental procedures or EEG recordings.
- • Individuals taking medications that could significantly affect pain perception (e.g., strong analgesics, sedatives).
- • Any contraindications for dental procedures or EEG recordings as determined by the study's dental and medical professionals.
- • Inability to understand and follow study instructions.
About Cleveland Dental Institute
Cleveland Dental Institute is a leading clinical research organization dedicated to advancing oral health through innovative research and development. With a commitment to enhancing clinical practices, the institute collaborates with dental professionals and academic institutions to conduct rigorous clinical trials focused on dental treatments, technologies, and therapies. By prioritizing patient safety and ethical standards, Cleveland Dental Institute aims to contribute to the scientific community and improve patient outcomes in dentistry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Ahmed A hashem, PhD
Study Director
CDI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported